These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 6279146)

  • 1. Binding of 2-azidoadenosine [beta-32P]diphosphate to the receptor on intact human blood platelets which inhibits adenylate cyclase.
    Macfarlane DE; Mills DC; Srivastava PC
    Biochemistry; 1982 Feb; 21(3):544-9. PubMed ID: 6279146
    [No Abstract]   [Full Text] [Related]  

  • 2. Prostacyclin increases cyclic AMP levels and adenylate cyclase activity in platelets.
    Best LC; Martin TJ; Russell RG; Preston FE
    Nature; 1977 Jun; 267(5614):850-2. PubMed ID: 197414
    [No Abstract]   [Full Text] [Related]  

  • 3. Adenosine 5-diphosphate antagonists and human platelets: no evidence that aggregation and inhibition of stimulated adenylate cyclase are mediated by different receptors.
    Cusack NJ; Hourani SM
    Br J Pharmacol; 1982 May; 76(1):221-7. PubMed ID: 6282375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of platelet adenylate cyclase by 1-O-alkyl-2-O-acetyl-sn-glyceryl-3-phosphorylcholine (platelet-activating factor).
    Haslam RJ; Vanderwel M
    J Biol Chem; 1982 Jun; 257(12):6879-85. PubMed ID: 6177688
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP.
    Haslam RJ; Davidson MM; Desjardins JV
    Biochem J; 1978 Oct; 176(1):83-95. PubMed ID: 215136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of ADP receptors.
    Cusack NJ; Hourani SM; Welford LA
    Adv Exp Med Biol; 1985; 192():29-39. PubMed ID: 3010670
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of human platelet adenylate cyclase by collagen fibres. Effect of collagen is additive with that of adrenaline, but interactive with that of thrombin.
    Farndale RW; Winkler AB; Martin BR; Barnes MJ
    Biochem J; 1992 Feb; 282 ( Pt 1)(Pt 1):25-32. PubMed ID: 1311555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of alpha 2-adrenoceptor agonists and of related compounds on aggregation of, and on adenylate cyclase activity in, human platelets.
    Clare KA; Scrutton MC; Thompson NT
    Br J Pharmacol; 1984 Jun; 82(2):467-76. PubMed ID: 6145472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desensitization of platelets to iloprost. Loss of specific binding sites and heterologous desensitization of adenylate cyclase.
    Jaschonek K; Faul C; Schmidt H; Renn W
    Eur J Pharmacol; 1988 Mar; 147(2):187-96. PubMed ID: 2452749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-Methylthioadenosine[beta-32P]diphosphate. An agonist and radioligand for the receptor that inhibits the accumulation of cyclic AMP in intact blood platelets.
    Macfarlane DE; Srivastava PC; Mills DC
    J Clin Invest; 1983 Mar; 71(3):420-8. PubMed ID: 6298277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of GTP in prostaglandin E1 stimulation of adenylate cyclase in platelet membranes.
    Stein JM; Martin BR
    Biochem J; 1983 Jul; 214(1):231-4. PubMed ID: 6684425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic AMP metabolism in cholesterol-rich platelets.
    Sinha AK; Shattil SJ; Colman RW
    J Biol Chem; 1977 May; 252(10):3310-4. PubMed ID: 193833
    [No Abstract]   [Full Text] [Related]  

  • 13. Competitive inhibition by adenosine 5'-triphosphate of the actions on human platelets of 2-chloroadenosine 5'-diphosphate, 2-azidoadenosine 5'-diphosphate and 2-methylthioadenosine 5'-diphosphate.
    Cusack NJ; Hourani SM
    Br J Pharmacol; 1982 Oct; 77(2):329-33. PubMed ID: 7139191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of adenosine on levels of adenosine cyclic 3',5'-monophosphate in human blood platelets in relation to adenosine incorporation and platelet aggregation.
    Haslam RJ; Rosson GM
    Mol Pharmacol; 1975 Sep; 11(5):528-44. PubMed ID: 170501
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of suramin on increases in cytosolic calcium and on inhibition of adenylate cyclase induced by adenosine 5'-diphosphate in human platelets.
    Hall DA; Hourani SM
    Biochem Pharmacol; 1994 Mar; 47(6):1013-8. PubMed ID: 8147900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of dextran sulfate, heparin and PGE1 on adenylate cyclase activity and aggregation of human platelets.
    Reches A; Eldor A; Salomon Y
    Thromb Res; 1979; 16(1-2):107-16. PubMed ID: 228444
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of a receptor for ADP on blood platelets by photoaffinity labelling.
    Cristalli G; Mills DC
    Biochem J; 1993 May; 291 ( Pt 3)(Pt 3):875-81. PubMed ID: 8387782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium-dependent proteolytic stimulation of adenylate cyclase in platelets from spontaneously hypertensive rats.
    Tremblay J; Hamet P
    Metabolism; 1984 Aug; 33(8):689-95. PubMed ID: 6087083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of adenyl-cyclase activators, phosphodiesterase inhibitors and pyridoxal-5-phosphate on platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation.
    Zahavi M; Zahavi J; Kakkar VV
    Thromb Haemost; 1984 Oct; 52(2):205-9. PubMed ID: 6098048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of protein kinase C activation on human platelet cyclic AMP metabolism.
    Bushfield M; Hopple SL; Gibson IF; Murdoch FA; MacIntyre DE
    FEBS Lett; 1987 Oct; 222(2):299-304. PubMed ID: 2820806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.